1-7 of 7
Chien-Chin Lin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes

Chi-Yuan Yao, Chien-Chin Lin, Yu-Hung Wang, Chein-Jun Kao, Cheng-Hong Tsai, Hsin-An Hou, Hwei-Fang Tien, Chia-Lang Hsu, Wen-Chien Chou
Journal: Blood Advances
Blood Adv (2024) 8 (10): 2442–2454.
https://doi.org/10.1182/bloodadvances.2023011512
Published: 2024
Includes: Supplemental data
Journal Articles

High BM plasma S100A8/A9 is associated with a perturbed microenvironment and poor prognosis in myelodysplastic syndromes

Yu-Hung Wang, Chien-Chin Lin, Chi-Yuan Yao, Fabio M. R. Amaral, Shan-Chi Yu, Chein-Jun Kao, Pin-Tsen Shih, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2528–2533.
https://doi.org/10.1182/bloodadvances.2022008958
Published: 2023
Includes: Supplemental data
Journal Articles

A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes

Clinical Trials & Observations
Yu-Hung Wang, Hsin-An Hou, Chien-Chin Lin, Yuan-Yeh Kuo, Chi-Yuan Yao, Chia-Lang Hsu, Mei-Hsuan Tseng, Cheng-Hong Tsai, Yen-Ling Peng, Chein-Jun Kao, Wen-Chien Chou, Hwei-Fang Tien
Journal: Blood Advances
Blood Adv (2021) 5 (22): 4535–4548.
https://doi.org/10.1182/bloodadvances.2021005141
Published: 2021
Includes: Supplemental data
Journal Articles

Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML

Clinical Trials & Observations
Cheng-Hong Tsai, Jih-Luh Tang, Feng-Ming Tien, Yuan-Yeh Kuo, Dung-Chi Wu, Chien-Chin Lin, Mei-Hsuan Tseng, Yen-Ling Peng, Mei-Fang Hou, Yi-Kuang Chuang, Ming-Chih Liu, Chia-Wen Liu, Ming Yao, Liang-In Lin, Wen-Chien Chou, Chien-Yu Chen, Hsin-An Hou, Hwei-Fang Tien
Journal: Blood Advances
Blood Adv (2021) 5 (10): 2456–2466.
https://doi.org/10.1182/bloodadvances.2020003738
Published: 2021
Includes: Supplemental data
Journal Articles

A 4-gene leukemic stem cell score can independently predict the prognosis of myelodysplastic syndrome patients

Clinical Trials & Observations
Yu-Hung Wang, Chien-Chin Lin, Chi-Yuan Yao, Chia-Lang Hsu, Hsin-An Hou, Cheng-Hong Tsai, Wen-Chien Chou, Hwei-Fang Tien
Journal: Blood Advances
Blood Adv (2020) 4 (4): 644–654.
https://doi.org/10.1182/bloodadvances.2019001185
Published: 2020
Includes: Supplemental data
Journal Articles

Phf6-null hematopoietic stem cells have enhanced self-renewal capacity and oncogenic potentials

Yueh-Chwen Hsu, Tsung-Chih Chen, Chien-Chin Lin, Chang-Tsu Yuan, Chia-Lang Hsu, Hsin-An Hou, Chein-Jun Kao, Po-Han Chuang, Yu-Ren Chen, Wen-Chien Chou, Hwei-Fang Tien
Journal: Blood Advances
Blood Adv (2019) 3 (15): 2355–2367.
https://doi.org/10.1182/bloodadvances.2019000391
Published: 2019
Includes: Supplemental data
Journal Articles

A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromes

Clinical Trials & Observations
Chi-Yuan Yao, Ching-Hsuan Chen, Huai-Hsuan Huang, Hsin-An Hou, Chien-Chin Lin, Mei-Hsuan Tseng, Chein-Jun Kao, Tzu-Pin Lu, Wen-Chien Chou, Hwei-Fang Tien
Journal: Blood Advances
Blood Adv (2017) 1 (19): 1505–1516.
https://doi.org/10.1182/bloodadvances.2017008284
Published: 2017
Includes: Supplemental data